资讯
Inclusion criteria also demanded that patients ... findings of NIS being common in patients with COPD and that depleted patients have more severe symptoms. Many of the investigated symptoms ...
The AUROC to estimate future severe exacerbations when using one previous severe COPD exacerbation within ... Current guidelines (GOLD criteria) use past flare-ups to predict risk, but new ...
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial. The headline ...
来自MSN9 个月
Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable MarketThe actual use of dupi in 20% of the 3.5 million moderate to severe COPD patients likely to be ... for dupi and relatively relaxed expected criteria for eosinophil counts. The analyst adds that ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果